Correction: Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy$dstudy protocol of the TRADE-hypo trial
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
10 August 2023
|
| In: |
BMC cancer
Year: 2023, Volume: 23, Issue: 1, Pages: 1 |
| ISSN: | 1471-2407 |
| DOI: | 10.1186/s12885-023-11270-x |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s12885-023-11270-x |
| Author Notes: | Farastuk Bozorgmehr, Inn Chung, Petros Christopoulos, Johannes Krisam, Marc A. Schneider, Lena Brückner, Daniel Wilhelm Mueller, Michael Thomas and Stefan Rieken |
| Item Description: | Gesehen am 23.07.2024 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 1471-2407 |
| DOI: | 10.1186/s12885-023-11270-x |